Lundbeck doubled its offer for Longboard over six months, new filing shows

Danish pharma Lundbeck vastly increased its offer to buy Longboard Pharmaceuticals over six months as other parties came to the dealmaking table, a new SEC filing shows. Lundbeck initially proposed $29 per share {$LBPH} on ...